Relapsed/refractory Burkitt lymphoma and HIV infection-Reference-Cited by-同舟云学术

Relapsed/refractory Burkitt lymphoma and HIV infection

Published:2017-12-21 Issue:7 Volume:29 Page:695-703
ISSN:0956-4624
Container-title:International Journal of STD & AIDS
language:en
Short-container-title:Int J STD AIDS

Author:

Khan Alina¹,Brahim Amanda¹^ORCID,Ruiz Marco¹,Nagovski Neil¹

Affiliation:

1. Memorial Cancer Institute, Memorial Hospital West, Pembroke Pines, FL, USA

Abstract

The care of patients with HIV and Burkitt lymphoma poses a challenge to clinicians. Due to the limited treatment options that exist for relapsed/refractory Burkitt lymphoma, there is a need for the development of new therapies. This review aims to discuss evidence for current management strategies including chemotherapy and stem cell transplant, and highlight gaps in knowledge that will need to be addressed in the future.

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Public Health, Environmental and Occupational Health,Dermatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0956462417748239

Reference24 articles.

1. Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma

2. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas

3. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

4. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

5. Linfoma de Burkitt en pacientes HIV positivo tratados con quimioterapia intensiva en el Hospital del Salvador entre 2011 y 2014: Protocolo Nacional de Cáncer del Adulto, Chile

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-associated lymphomas;Creative surgery and oncology;2023-01-05

2. Amplifications of AURKA and AURKB in a Burkitt lymphoma immunodeficiency-associated type: a case report;einstein (São Paulo);2023

3. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates – A multicenter cohort study;Leukemia Research;2020-02